Vance Fredrickson

Vance Fredrickson

Auto-generated profile, based on publicly available information

Vance Fredrickson

Neurosurgery, BNI, Phoenix, AZ

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

22 December 2021 in Operative Neurosurgery
Verified
Journal Article
Closed access
VFVance L. Fredrickson
Vance L. Fredrickson
GAGuilherme J. Agnoletto
Guilherme J. Agnoletto
THTodd C. Hollon
Todd C. Hollon
BKBornali Kundu
Bornali Kundu
VMVance R. Mortimer
Vance R. Mortimer
PTPhilipp Taussky
Philipp Taussky
BACKGROUND AND IMPORTANCE: There is no consensus on the optimal surgical approach for managing optic nerve gliomas. For solely intraorbital tumors, a single-stage lateral orbitotomy approach for resection may be performed, but when the nerve within the optic canal is affected, two-stage cranial and orbital approaches are often used. The authors describe their technique to safely achieve aggressive nerve resection to minimize the probability of recurrence that might affect the optic tracts, optic chiasm, and contralateral optic nerve. CLINICAL PRESENTATION: A 28-yr-old woman presented with painless progressive vision loss, resulting in blindness. The second of 2 transorbital biopsies was diagnostic and consistent with low-grade glioma. The lesion continued to grow on serial imaging. The patient was offered a globe-sparing operative approach, with aggressive resection of the lesion to minimize the probability of tumor recurrence, which could possibly affect vision in her contralateral eye. The patient did well postoperatively, with clean tumor margins on pathological analysis and no evidence of residual on imaging. On postoperative examination, she had a mild ptosis, which was nearly resolved at her 6-wk outpatient follow-up. CONCLUSION: This aggressive single-stage en bloc resection of an optic nerve glioma can achieve excellent tumor margins and preservation of extraocular muscle function.

15 July 2021 in Cureus
Verified
Journal Article
Open access
AGAustin Gamblin
Austin Gamblin
SNSarah Nguyen
Sarah Nguyen
VFVance Fredrickson
Vance Fredrickson
RGRamesh Grandhi
Ramesh Grandhi
PTPhilipp Taussky
Philipp Taussky
Postoperative digital subtraction angiography (DSA) is the gold standard for establishing a cure of an arteriovenous malformation (AVM) after treatment. The incidence of residual AVM identified on postoperative DSA ranges from 1.8 to 11%. Although this is important for finalizing the treatment of AVMs, postoperative DSA rarely shows new findings that were not previously identified on preoperative imaging. We present a unique case where we identified residual AVM nidus on immediate postoperative DSA that drained into two deep veins that were not evident on preoperative DSA and increased the AVM grade from Spetzler-Martin grade II to III. To our knowledge, this finding has not been previously reported in the literature. We resected the residual AVM nidus identified on postoperative DSA, leading to an angiographic cure. The patient demonstrated a postoperative right-sided supplementary motor area syndrome that resolved over time with therapy. She made a complete functional recovery by her one-month follow-up appointment.

4 August 2020
Verified
Conference Paper
Open access
PDF file
JCJ Catapano
J Catapano
CNC Nguyen
C Nguyen
CKC Korson
C Korson
JBJ Baranoski
J Baranoski
TCT Cole
T Cole
ADA Ducruet
A Ducruet
Background Vertebral artery dissecting aneurysms (VADAs) are a rare cause of subarachnoid hemorrhage associated with high rates of morbidity and mortality. Ruptured non-dominant VADAs are traditionally treated via endovascular coil-occlusion. However, controversy exist for the appropriate management of unruptured VADAs and ruptured dominant VADAs. To the authors knowledge, this is the largest single-center study comparing modern neuroendovascular neurosurgical treatment strategies, including flow diversion (FD), to treat VADAs. Methods All patients with a VADA treated endovascularly at a single center from January 1st, 1999 to December 31st, 2019 were retrospectively analyzed from a prospectively collected database. VADAs were categorized as either dominant or non-dominant vertebral artery. Furthermore, location of the VADA was classified as either the proximal V4 segment of the vertebral artery (proximal to PICA), incorporating PICA origin, or (distal V4) distal to PICA. Primary neurological outcomes were measured via mRS, with a mRS >2 categorized as a poor neurological outcome and a decline in mRS from the preoperative neurological exam as a worse neurological outcome. Secondary outcomes included retreatment rate and complications. Results 91 patients underwent endovascular treatment for a VADA over this 20-year period (44 patients underwent open microsurgical intervention). 77 (85%) VADAs were on the proxmial V4 segment, 8 (9%) included the PICA origin, and 6 (7%) arose distal to PICA. Coil-occlusion was performed in 47 (51%), FD in 29 (32%), and stent/coil in 15 (17%) cases. 54 patients (59%) presented with SAH (treated via coil-occlusion in 39, FD in 7, and stent/coil in 8 cases; p<0.001) and 44 VADAs (48%) involved a dominant vertebral artery (all dominant vertebral arteries were treated by either a FD or stent/coil; p<0.001). Rates of complications and retreatment were both significantly higher in patients treated with stent/coil ( complication: N=4, 27%, retreatment: N=6, 40%) vs either coil-occlusion (complication: N=1, 2%, retreatment=2, 4%) or FD (complication: N=2, 7%, retreatment: N=4, 14%) (p=0.008 and p=0.002, respectively). Preoperative mRS was significantly higher in patients treated with coil-occlusion (3.2±1.4)than FDD (1.9±1.5)or stent/coil (1.8±1.3) (p2 on follow-up than FDD (4, 14%) or stent/coil (3, 20%) (p=0.006). For dominant vertebral arteries, stent/coil (6, 40%) required greater percentage of retreatments than FD (4, 14%) (p=0.049). Of the unruptured VADAs (N=37), 1 patient suffered a complication (3%), 4 patients (11%) required retreatment, 2 patients (5%) had mRS >2, and 8 patients (22%) exhibited a decline in mRS on follow-up, with no significant difference between the treatments. Conclusion The majority of ruptured VADAs at our center were treated by coil-occlusion of non-dominant vertebral artery. For dominant vertebral arteries, FD required less retreatment than stent/coil cases. Furthermore, endovascular treatment of unruptured VADAs is safe and associated with favorable angiographic and neurological outcomes. Disclosures J. Catapano: None. C. Nguyen: None. C. Korson: None. J. Baranoski: None. T. Cole: None. N. Majmundar: None. D. Wilkinson: None. V. Fredrickson: None. F. Albuquerque: None. A. Ducruet: None.

4 August 2020
Verified
Conference Paper
Open access
PDF file
JCJ Catapano
J Catapano
CNC Nguyen
C Nguyen
VFV Fredrickson
V Fredrickson
NMN Majmundar
N Majmundar
DWD Wilkinson
D Wilkinson
FAF Albuquerque
F Albuquerque
Background Transradial artery (TRA) catheterization for neuroendovascular procedures is effective and associated with less complications than transfemoral procedures. However, the majority of literature for TRA is limited to series with a high proportion of diagnostic procedures as opposed to interventional treatments. The present study compares TRA and TFA approaches for cerebrovascular intervention. Methods All patients with an endovascular intervention from 10/1/2018 to 12/31/2019 performed at a single center were retrospectively analyzed. Patients were grouped into two cohorts: those undergoing TRA and TFA access. Primary outcomes included complications and access site cross-over. Secondary outcomes analyzed were mean fluoroscopy time and contrast amount. Results A total of 579 neurointerventional treatment procedures were performed during the 15-month study period. 163 (28%) procedures were initially attempted via a TRA and the remaining 416 (72%) via TFA. Of the 163 initially- attempted TRA procedures, 7 (4%) crossovers (4 aneurysm embolizations, 2 thrombectomies for acute stroke, and 1 AVM embolization with 6 crossing over to TFA) vs 13 (3.1%) (5 crossing over to TRA) in the TFA procedures occurred (p=0.49). Of the 162 TRA neurointerventional procedures that were carried out accounting for crossovers, 80 (35%) were for aneurysmal embolization, 31 embolization (19%) of an AVM and/or AVF, 4 (3%) thrombectomies of an acute stroke, 9 (6%) carotid artery stenting/angioplasty, 8 (5%) embolization of a tumor, 24 (15%) middle meningeal artery embolization for chronic subdural hematomas, and 6 (4%) other neurointerventions. The TRA procedures were significantly different than the 417 TFA procedures performed, which included 143 (34%) thrombectomies for acute stroke (p<0.001). A significantly greater fluoroscopy time (39 vs 30 minutes) and total contrast (156 vs 128 mL) were observed in the TRA procedures (p<0.001 for both). TFA procedures (N=43, 10%) were associated with a significantly higher complication rate than TRA procedures (N=5, 4%) (p=0.008); however, the majority of complications were mild with only 18 (3%) major complications including 3 (2%, all IPH or CVA) in the TRA procedures and 15 (3.6%; 6 IPH/CVA, 5 vessels dissections, 3 femoral occlusions, and 1 retroperitoneal bleed) in the TFA interventions. After eliminating thrombectomy patients and performing a propensity adjustment (including age, gender, symptoms, procedure, pathology, sheath and catheter size) TRA catheterization was associated with decreased odds of a complication (OR 0.25, 95% CI: 0.085–0.72, p=0.011) and a greater contrast amount (161 vs 140 mL, p=0.007), but no significant difference in fluoroscopy time (39 vs 35 minutes, p=0.052) than TFA treatments. Conclusion TRA access for neuroendovascular interventions can be performed successfully for a variety of procedures and for numerous pathologies, with fewer overall complications and no difference in fluoroscopy times than the traditional TFA approach. Disclosures J. Catapano: None. C. Nguyen: None. V. Fredrickson: None. N. Majmundar: None. D. Wilkinson: None. J. Baranoski: None. T. Cole: None. A. Ducruet: None. F. Albuquerque: None.